Developments in Glycopeptide Antibiotics

Author:

Blaskovich Mark A. T.12ORCID,Hansford Karl A.12ORCID,Butler Mark S.12ORCID,Jia ZhiGuang12,Mark Alan E.12ORCID,Cooper Matthew A.12ORCID

Affiliation:

1. Institute for Molecular Bioscience, The University of Queensland, 306 Carmody Road, Brisbane, Queensland 4072, Australia

2. School of Chemistry and Molecular Biosciences, The University of Queensland, Chemistry Building 68, Cooper Road, Brisbane, Queensland 4072, Australia

Funder

National Health and Medical Research Council

Wellcome Trust

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Reference175 articles.

1. Antibiotics in the clinical pipeline at the end of 2015

2. Antibiotics in late clinical development

3. World Health Organization. (2017) Antibacterial agents in clinical development: An analysis of the antibacterial clinical development pipeline, including tuberculosis, WHO/EMP/IAU/2017.11, WHO, Geneva, http://apps.who.int/iris/bitstream/10665/258965/1/WHO-EMP-IAU-2017.11-eng.pdf?ua=1 (accessed 22 November 2017).

4. Grayeff, Y. (2014) Cubist Q4 revenues + 22%; Cubicin annual sales top $1B, https://seekingalpha.com/news/1503931-cubist-q4-revenues-plus-22-percent-cubicin-annual-sales-top-1b (accessed 22 November 2017).

5. CDC. (2013) Antibiotic Resistance Threats in the United States, 2013, U.S. Department of Health and Human Services (Centers for Disease Control and Prevention), Atlanta, http://www.cdc.gov/drugresistance/threat-report-2013 (accessed 22 November 2017).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3